Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Oliver Tannous

Orthopaedic Surgery of the Spine San Diego, CA Medical Doctor

NPI 1285952655 CMS profile 1374786

350 Dickinson St, Suite 121, Mc 8894, San Diego, CA 92103

Open in the dashboard

General payments

$566,064

473 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Oliver Tannous of San Diego, CA is reported in the CMS Open Payments database as having received $566,064 across 473 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $158,200 93
2024 General $156,867 100
2023 General $78,123 63
2022 General $135,145 93
2021 General $27,739 67
2020 General $6,502 25
2019 General $3,488 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Oliver Tannous
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Oliver Tannous were reported at $158,200. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Oliver Tannous Orthopaedic Surgery of the Spine median Middle half National median
2019 $3,488 $2,106 $337–$18,608 $163
2020 $6,502 $1,213 $156–$15,082 $114
2021 $27,739 $1,834 $271–$15,617 $132
2022 $135,145 $2,015 $320–$17,036 $149
2023 $78,123 $1,925 $336–$14,599 $160
2024 $156,867 $2,110 $341–$12,483 $164
2025 $158,200 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medacta USA, Inc. $420,660 245 payments
  2. Innovasis Inc $48,625 38 payments
  3. Baxter Healthcare $18,933 24 payments
  4. Precision Spine, Inc. $16,753 10 payments
  5. Centinel Spine, LLC $15,683 8 payments
  6. Cerapedics, Inc. $15,209 16 payments
  7. Kuros Biosciences USA, Inc $8,145 10 payments
  8. NuVasive, Inc. $5,020 14 payments
  9. 4WEB, Inc. $3,322 6 payments
  10. Stryker Corporation $2,090 17 payments
  11. Other $11,625 85 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $468,801 70 payments
  2. Travel and Lodging $72,679 167 payments
  3. Food and Beverage $23,507 227 payments
  4. Education $577 8 payments
  5. Honoraria $500 1 payment
Products named General payments · program years 2019–2025
  1. MySpine Orthopedics/Orthopedic Surgery $133,671 51 payments
  2. MySpine Spine $77,106 44 payments
  3. MYSPINE Spine $59,776 92 payments
  4. MECTALIF $28,435 2 payments
  5. Mecta-C Cervical Cages $21,350 1 payment
  6. MUST Orthopedics/Orthopedic Surgery $18,804 21 payments
  7. FLOSEAL $18,325 18 payments
  8. MUST Spine $16,390 7 payments
  9. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $14,709 15 payments
  10. MUST MINI Set Screw $10,146 6 payments
  11. Other $78,732 194 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

142

Median for Orthopedic Surgery: 203

Drug cost

$4,161

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lidocaine Generic 34 $3,204
Cyclobenzaprine Hcl Generic 45 $455
Gabapentin Generic 38 $430
Meloxicam Generic 12 $44
Alprazolam Generic 13 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 93 billing codes

Paid by Medicare

$363,867

Medicare's payments for the services billed

Medicare patients

455

Average age 73

Services billed

1,236

282 women, 173 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 47%
Ischemic heart disease 32%
Chronic kidney disease 29%
Depression 17%
COPD 15%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

473 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record